Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AS 1387392

Known as: AS-1387392, AS1387392 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cyclic Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase
It has come to the Editors’ attention that background information relevant to these recently published articles was incomplete… Expand
2010
2010
AS1387392, a novel immunosuppressive cyclic tetrapeptide compound with inhibitory activity against mammalian histone deacetylase
The novel immunosuppressant AS1387392 has been isolated from Acremonium sp. No. 27082. This compound showed a strong inhibitory… Expand
  • figure 2
  • figure 1
  • table 1
  • figure 3
  • table 4
2010
2010
Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392
Biotransformation technology involving enzymatic modification of original substrates by organisms such as microbes is a valuable… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2010
2010
Bioconversion of AS1387392: screening and characterization of actinomycetes that convert AS1387392 to AS1429716
AS1387392 was a novel and powerful histone deacetylase inhibitor with an excellent oral absorption profile, but this compound was… Expand
  • figure 1
  • figure 2
  • table 1
  • table 3
  • table 2
2010
2010
Bioconversion of AS1387392: bioconversion studies involving Amycolatopsis azurea JCM 3275
We screened actinomycetes capable of converting AS1387392 to AS1429716 and identified those strains capable of hydroxylation… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE